Order results by:
| Issue | Title | |
| Vol 6, No 2 (2013) | PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION | Abstract similar documents |
| V. A. Chibilyaev, A. Yu. Kulikov, R. I. Yagudina | ||
| "... the advantages of therapeutic strategy with higher access to ART (strategy B). In particular, the results ..." | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic | Abstract similar documents |
| Yu. Sh. Gushchina, А. Yu. Abramov, Y. J. Haitham | ||
| "... patients. Objective: to perform pharmacoeconomic analysis of ART regimens HIV-infected in patients in SAR ..." | ||
| Vol 6, No 3 (2013) | THE MONITORING RESEARCHES OF HIV/AIDS ON THE BASIS OF THE SITUATION ANALYSIS | Abstract similar documents |
| N. B. Dremova, I. V. Alekseev | ||
| "... We present the results of the analysis of the monitoring of HIV / AIDS in the regions ..." | ||
| Vol 8, No 2 (2015) | ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA | Abstract similar documents |
| Elamin H. Elbasha, Elena Aleksandrovna Pyadushkina, Maria Vladimirovna Avxentyeva, Alexander Gennadievich Tolkushin, Maxim Yurievich Frolov | ||
| "... of protease inhibitors with adult patients with Type 1 HIV infection (HIV-1) that have no experience ..." | ||
| Vol 10, No 2 (2017) | COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS | Abstract similar documents |
| M. B. Kubaeva, Y. Sh. Guchshina | ||
| "... of anti-HIV drugs. Material and methods. The study was based on the documented medical histories of HIV ..." | ||
| Vol 5, No 2 (2012) | WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM | Abstract similar documents |
| A. I. Borodin | ||
| "... necessity of working out the scientifically-proved strategy of storekeeping by different groups of medicines ..." | ||
| Vol 10, No 3 (2017) | The strategies of drug supply for patients with chronic hepatitis C | Abstract similar documents |
| E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin | ||
| Vol 13, No 1 (2020) | Health technology assessment in obstetrics: advantage of tailored conservative strategy vs surgical therapies of monochorionic twin complicated by TRAP-sequence | Abstract similar documents |
| V. I. Tsibizova, I. E. Govorov, I. I. Averkin, N. M. Khamani, D. V. Blinov | ||
| Vol 16, No 1 (2023) | Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022 | Abstract similar documents |
| D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, M. A. Polzikov, A. S. Semikhin | ||
| "... technologies (ART). Material and methods. Clinical and economic evaluation of follitropin alfa use in patients ..." | ||
| Vol 15, No 1 (2022) | Pharmacoeconomic analysis of the application of follitropin alfa in combination with assisted reproductive technologies | Abstract similar documents |
| K. A. Perova, D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, N. Z. Musina | ||
| "... ovarian response, who undergo treatment with assisted reproductive technologies (ART). Material ..." | ||
| Vol 16, No 2 (2023) | Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination | Abstract similar documents |
| I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova | ||
| "... of assisted reproductive technology (ART) programs – in vitro fertilization (IVF) or intracytoplasmic sperm ..." | ||
| Vol 14, No 2 (2021) | Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation | Abstract similar documents |
| D. G. Shchurov, V. S. Dombrovskiy | ||
| "... in infertile patients undergoing treatment with assisted reproductive technologies (ART), as well as the impact ..." | ||
| Vol 6, No 3 (2013) | ECONOMIC EVALUATION OF THE EFFECTIVENESS OF LOW MOLECULAR WEIGHT HEPARIN AND INTERMITTENT PNEUMATIC COMPRESSION IN WOMEN IN A CYCLE OF IN VITRO FERTILIZATION | Abstract similar documents |
| A. P. Momot, I. V. Molchanova, N. A. Semenova, O. P. Tomilina, E. A. Elykomov, O. G. Borisova | ||
| "... To solve the problem of infertility in the world assisted reproductive technologies (ART ..." | ||
| Vol 16, No 3 (2023) | Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia | Abstract similar documents |
| A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva | ||
| "... Background. The global recommendations for the treatment strategy of community-acquired pneumonia ..." | ||
| Vol 8, No 1 (2015) | BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD | Abstract similar documents |
| A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
| "... shown that use of bendamustine in comparing with strategy of a bortezomib is more preferable strategy ..." | ||
| Vol 11, No 3 (2018) | The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia | Abstract similar documents |
| V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina | ||
| "... the principles of health technologies assessment (HTA) and the reimbursement strategies in Russia have been put ..." | ||
| Vol 6, No 4 (2013) | Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital | Abstract similar documents |
| A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
| "... strategy in surgical and therapeutic patients. The additional model included the patient with signigicant ..." | ||
| Vol 9, No 3 (2016) | COPAYMENTS OF THE CITIZENS IN HEALTHCARE SYSTEM: INTERNATIONAL PRACTICE | Abstract similar documents |
| A. P. Tatarinov, D. V. Lukyantseva, L. S. Melnikova, V. V. Omelyanovskii | ||
| "... to the citizens free of charge, has almost no upper limit. In light of this, the alternative strategies of more ..." | ||
| Vol 11, No 2 (2018) | Implementation of the Federal Law «On Protection of Consumer Rights» in the provision of paid medical services: recommendations on signing the contract | Abstract similar documents |
| M. A. Amkhadova, E. V. Batler, D. G. Ilyuhin, I. A. Petrova | ||
| "... , the choice of treatment and the optimal strategies, including those in dental practice, are also discussed. ..." | ||
| Vol 6, No 2 (2013) | FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS | Abstract similar documents |
| A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure | ||
| "... of type 2 DM complications in 5 years in patient with predefined risk factors. Among comparing strategies ..." | ||
| Vol 11, No 1 (2018) | CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation | Abstract similar documents |
| A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin | ||
| "... to the antipsychotic therapy were shown to be a cost-effective strategy as it gives additional clinical ..." | ||
| Vol 13, No 2 (2020) | Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation | Abstract similar documents |
| S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova | ||
| "... compared treatment strategies. The cost savings in favor of T+O were 24.82% [15.86–29.95%]. The application ..." | ||
| Vol 7, No 1 (2014) | PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE | Abstract similar documents |
| S. A. Rachina, R. S. Kozlov, Yu. A. Belkova | ||
| "... of indications lists for well recognized drugs, as well as changes in treatment strategies and prognosis for many ..." | ||
| Vol 7, No 3 (2014) | ECONOMIC JUSTIFICATION FOR TELEHEALTH TECHNOLOGY USE FOR PREVENTIVE MEDICAL EXAMINATION OF THE POPULATION IN REMOTE REGIONS | Abstract similar documents |
| D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky | ||
| "... Okrug – Yugra. The model developed medicoeconomic assumes comparison of two possible strategy ..." | ||
| Vol 14, No 2 (2021) | Artificial intelligence in healthcare: possibilities of patent protection | Abstract similar documents |
| T. N. Erivantseva, Yu. V. Blokhina | ||
| "... patent protection and its strategy in the leading areas of AI use in healthcare are considered ..." | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic aspects of COVID-19 treatment | Abstract similar documents |
| I. V. Rogova, E. A. Zhidkova, I. A. Popova, A. V. Zaborovskiy, K. G. Gurevich | ||
| "... in terms of pharmacoeconomic effectiveness. Different strategies for managing patients with the new ..." | ||
| Vol 16, No 4 (2023) | Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma | Abstract similar documents |
| S. K. Zyryanov, K. V. Orlova | ||
| "... .2 months for the strategy starting with “dabrafenib + trametinib” combination. The number of LYGs ..." | ||
| Vol 15, No 4 (2022) | Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention | Abstract similar documents |
| V. А. Ryagina, К. I. Matrenin, D. G. Shchurov, Т. S. Teptsova | ||
| "... with atrial fibrillation (AF) who underwent PCI; to identify the impact of the above strategies ..." | ||
| Vol 14, No 3 (2021) | The concept of syndromic diagnoses of osteoarthritis and back pain as a cause of therapy failure | Abstract similar documents |
| M. V. Putilina, N. V. Teplova, O. S. Gerasimova | ||
| "... simultaneously exist. The treatment strategies for back pain do not take into account chronic inflammation ..." | ||
| Vol 15, No 1 (2022) | A systematic review of real-world clinical practice data in COVID-19: non-interventional studies | Abstract similar documents |
| S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov | ||
| "... . A search strategy for the terms “COVID-19 AND real-life”, “COVID-19 AND real-data”, “COVID-19 AND real ..." | ||
| Vol 15, No 1 (2022) | Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system | Abstract similar documents |
| D. V. Blinov, A. G. Solopova, A. N. Plutnitskiy, D. M. Ampilogova, L. N. Sandzhieva, D. I. Korabel’nikov, D. A. Petrenko | ||
| "... strategy can reduce pharmacoeconomical burden for the health care system. However, further clinical ..." | ||
| Vol 15, No 1 (2022) | The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies | Abstract similar documents |
| A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem | ||
| "... considered only the deviation of the price of the strategies under consideration, and in a quarter of cases ..." | ||
| Vol 16, No 3 (2023) | Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study | Abstract similar documents |
| A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina | ||
| "... to the equivalence of strategies regarding overall and non-progressive survival, the cost minimization analysis ..." | ||
| Vol 10, No 4 (2017) | PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION | Abstract similar documents |
| M. Yu. Frolov, V. A. Rogov | ||
| "... The aim – assess the clinical advantages and economic burden of various treatment strategies ..." | ||
| Vol 16, No 3 (2023) | Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer | Abstract similar documents |
| I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova | ||
| "... (for CP/EP + Durv, 316,421.24 and 800,359.60 rubles, respectively). When choosing the CP/ET + ATZ strategy ..." | ||
| Vol 7, No 3 (2014) | PHARMACOEPIDEMIOLOGY OF ORIGINAL DROTAVERINE USE IN DYSMENORRHEA: RESULTS OF AN INTERNATIONAL MULTICENTER STUDY | Abstract similar documents |
| A. L. Unanyan, V. A. Alimov, S. E. Arakelov, M. S. Afanasyev, D. V. Baburin, D. V. Blinov, T. D. Guriyev, U. V. Zimovina, A. E. Kadyrova, Yu. M. Kossovich, L. S. Polonskaya | ||
| "... visits), non-interventional on the therapeutic strategy was conducted in Mexico, Kazakhstan, and Russia ..." | ||
| Vol 11, No 1 (2018) | Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia | Abstract similar documents |
| I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
| "... was analyzed for different time intervals – 6, 12 and 24 months. As shown, the treatment strategies involving ..." | ||
| Vol 11, No 2 (2018) | Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia | Abstract similar documents |
| I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
| "... intervals – 6, 12 and 24 months. As shown, the treatment strategies involving AA were more budget ..." | ||
| Vol 15, No 2 (2022) | Improving the efficiency of the medicine provision system for patients with malignant neoplasms | Abstract similar documents |
| Yu. A. Agafonova, D. V. Fedyaev, A. V. Snegovoy, V. V. Omelyanovskiy | ||
| "... strategies to address the access to cancer medicines is needed. ..." | ||
| Vol 13, No 2 (2020) | Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation | Abstract similar documents |
| S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva | ||
| "... associated with the treatment for ischemic stroke were lower by 28.1% The strategy of the application of DOAC ..." | ||
| Vol 15, No 1 (2022) | The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 | Abstract similar documents |
| I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova | ||
| "... at reducing high blood pressure and hypercholesterolemia is seen as an effective strategy for reducing ..." | ||
| Vol 16, No 4 (2023) | Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development | Abstract PDF (Eng) similar documents |
| V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan | ||
| "... of the action in question. The SWOT analysis showed a possible strategy for developing and launching a new drug ..." | ||
| Vol 17, No 2 (2024) | Clinical and economic assessment of using topical bacterial lysate Imudon® for the treatment and prevention of acute upper respiratory tract infections in children | Abstract similar documents |
| A. R. Kasimova, A. S. Kolbin | ||
| "... to the therapeutic strategy associated with the use of local antiseptics. Conclusion. For the first time in Russian ..." | ||
| Vol 17, No 2 (2024) | Mathematical modeling and analysis of export trends for certain pharmaceutical groups | Abstract similar documents |
| А. R. Shaikhislamova, N. А. Gasratova | ||
| "... market. The obtained results can be useful for developing strategies of the pharmaceutical industry ..." | ||
| Vol 12, No 2 (2019) | Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU | Abstract similar documents |
| G. N. Gildeeva, A. V. Belostotsky | ||
| "... countries in order to adopt the strategy of the pharmaceutical industry players. Materials and methods ..." | ||
| Vol 16, No 4 (2023) | Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C | Abstract similar documents |
| I. A. Narkevich, E. A. Tsitlionok | ||
| "... have practical implications for building a strategy for hepatitis C virus elimination in terms ..." | ||
| Vol 8, No 1 (2015) | PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE | Abstract similar documents |
| D. V. Blinov, U. V. Zimovina, T. I. Ushakova | ||
| "... and methods. 2450 patients were included in 98 sites. Non-interventional on therapeutic strategy study ..." | ||
| Vol 12, No 2 (2019) | New framework for the development of clinical guidelines in Russia | Abstract similar documents |
| D. V. Blinov, E. S. Akarachkova, A. S. Orlova, E. V. Kryukov, D. I. Korabelnikov | ||
| "... . Discussion. The unification of treatment strategies and the use of evidence-based reasoning in the updated CG ..." | ||
| Vol 14, No 1 (2021) | Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19 | Abstract similar documents |
| O. V. Zhukova, A. L. Khokhlov | ||
| "... that is characterized by an increased secretion of anti-inflammatory cytokines. Thus, one of the leading strategies ..." | ||
| Vol 18, No 1 (2025) | Clinical and diagnostic significance of isolated detection of IgA antibodies to deamidated gliadin peptides in IgA nephropathy patients | Abstract similar documents |
| M. E. Mantsaeva, D. I. Korabelnikov, A. G. Borisov | ||
| "... strategies. Material and methods. A total of 105 IgAN patients aged 18 to 64 years participated ..." | ||
| 1 - 50 of 50 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
